The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (14.55) USD. With the latest stock price at 8.16 USD, the upside of Neogenomics Inc based on DCF is -278.4%.
Based on the latest price of 8.16 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 278.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.4% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (36.08) - (9.97) | (14.55) |
| Upside | -542.2% - -222.2% | -278.4% |